Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-21 Sale |
2025-03-25 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
174 | $10 | $1,740 | 2,824,844 (Indirect) |
View |
2025-03-19 Sale |
2025-03-21 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.11 | $40,440 | 2,825,018 (Indirect) |
View |
2025-03-17 Sale |
2025-03-19 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,242 | $11.89 | $26,658 | 2,829,018 (Indirect) |
View |
2025-03-13 Sale |
2025-03-17 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.05 | $48,220 | 2,831,260 (Indirect) |
View |
2025-03-11 Sale |
2025-03-13 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.57 | $46,280 | 2,835,260 (Indirect) |
View |
2025-03-07 Sale |
2025-03-11 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.19 | $40,776 | 2,839,260 (Indirect) |
View |
2025-03-05 Sale |
2025-03-07 4:02 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.89 | $43,560 | 2,843,260 (Indirect) |
View |
2025-03-03 Sale |
2025-03-05 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.04 | $44,180 | 2,847,260 (Indirect) |
View |
2025-02-27 Sale |
2025-03-03 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.37 | $45,480 | 2,851,260 (Indirect) |
View |
2025-02-25 Sale |
2025-02-27 4:02 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.5 | $46,000 | 2,855,260 (Indirect) |
View |
2025-02-21 Sale |
2025-02-25 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.3 | $45,190 | 2,859,260 (Indirect) |
View |
2025-02-19 Sale |
2025-02-21 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.35 | $49,380 | 2,863,260 (Indirect) |
View |
2025-02-14 Sale |
2025-02-19 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.21 | $48,860 | 2,867,260 (Indirect) |
View |
2025-02-12 Sale |
2025-02-14 4:00 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.59 | $46,360 | 2,871,260 (Indirect) |
View |
2025-02-10 Sale |
2025-02-12 8:45 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
3,878 | $11.72 | $45,435 | 2,875,260 (Indirect) |
View |
2025-02-06 Sale |
2025-02-11 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.51 | $50,020 | 2,879,158 (Indirect) |
View |
2025-02-04 Sale |
2025-02-06 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.01 | $48,029 | 2,883,138 (Indirect) |
View |
2025-01-31 Sale |
2025-02-04 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.49 | $45,960 | 2,887,138 (Indirect) |
View |
2025-01-29 Sale |
2025-01-31 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.4 | $45,600 | 2,891,138 (Indirect) |
View |
2025-01-27 Sale |
2025-01-29 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.35 | $45,380 | 2,895,138 (Indirect) |
View |
2025-01-23 Sale |
2025-01-27 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.69 | $42,760 | 2,899,138 (Indirect) |
View |
2025-01-21 Sale |
2025-01-24 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.74 | $42,960 | 2,903,138 (Indirect) |
View |
2025-01-16 Sale |
2025-01-21 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.71 | $42,860 | 2,907,138 (Indirect) |
View |
2025-01-14 Sale |
2025-01-16 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.62 | $42,480 | 2,911,138 (Indirect) |
View |
2025-01-10 Sale |
2025-01-14 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
1,113 | $10.02 | $11,157 | 2,915,138 (Indirect) |
View |
2025-01-03 Sale(A) |
2025-01-10 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
833 | $11.85 | $9,871 | 2,918,467 (Indirect) |
View |
2025-01-06 Sale |
2025-01-08 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
2,216 | $10.08 | $22,336 | 2,916,251 (Indirect) |
View |
2024-01-03 Sale |
2025-01-06 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.89 | $47,543 | 2,918,467 (Indirect) |
View |
2024-12-30 Sale |
2025-01-02 4:06 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.4 | $49,600 | 2,922,467 (Indirect) |
View |
2024-12-26 Sale |
2024-12-30 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.64 | $50,553 | 2,926,467 (Indirect) |
View |
2024-12-23 Sale |
2024-12-26 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $12.1 | $48,399 | 2,930,467 (Indirect) |
View |
2024-12-19 Sale |
2024-12-23 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $10.86 | $43,440 | 2,934,467 (Indirect) |
View |
2024-12-17 Sale |
2024-12-19 4:01 pm |
GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President |
4,000 | $11.21 | $44,852 | 2,938,467 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-16 Exercise |
2025-04-18 5:27 pm |
N/A N/A |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
15,000 | $6.93 | 314,652 (Direct) |
View |
2025-04-16 Exercise |
2025-04-18 5:27 pm |
N/A 2033-10-31 |
GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director |
15,000 | $0 | 314,652 (Direct) |
View |
2025-03-07 Option Award |
2025-03-11 8:00 pm |
N/A 2035-03-07 |
GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer |
300,000 | $0 | 300,000 (Direct) |
View |
2025-01-05 Option Award |
2025-01-07 4:05 pm |
N/A 2035-01-05 |
GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director |
52,000 | $0 | 52,000 (Direct) |
View |
2024-08-14 Option Award |
2024-08-16 9:13 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director |
52,000 | $0 | 52,000 (Direct) |
View |
2024-08-14 Option Award |
2024-08-16 9:10 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director |
52,000 | $0 | 52,000 (Direct) |
View |
2024-08-14 Option Award |
2024-08-16 9:07 pm |
N/A 2034-08-14 |
GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director |
52,000 | $0 | 52,000 (Direct) |
View |